west china medical publishers
Author
  • Title
  • Author
  • Keyword
  • Abstract
Advance search
Advance search

Search

find Author "AN Zhenmei" 3 results
  • Influence of Hydrochloric Acid to the Measurement of Free Cortisol in 24-hour Urine

    目的 研究尿标本中防腐剂盐酸对24 h尿游离皮质醇测定的影响。 方法 收集2008年7月-2009年1月正常人、库欣病患者及其他疾病患者的24 h尿液,混匀后,一部分浓盐酸防腐,一部分未加盐酸直接保存。电化学发光免疫分析法同步检测尿游离皮质醇浓度。 结果 经配对 t 检验加浓盐酸后的24 h尿游离皮质醇测值均高于未加酸者,比较有统计学意义(Plt;0.05)。加盐酸和未加盐酸所测尿游离皮质醇二者之间具有较好的相关性,相关系数 r =0.97,P lt;0.05。 结论 浓盐酸防腐的标本24 h尿游离皮质醇测值较未加酸保存的标本高。因此,为了得到相对准确的值,更好地反映肾上腺实际分泌情况,测定24 h尿游离皮质醇的标本不应使用盐酸防腐。

    Release date:2016-09-08 09:49 Export PDF Favorites Scan
  • Effects of Venlafaxine and Carbamazepine for Painful Peripheral Diabetic Neuropathy: A Randomized, Double-blind and Double-dummy, Controlled Multi-center Trial

    Objective To evaluate the safety and efficacy of venlafaxine and carbamazepine on painful peripheral diabetic neuropathy. Methods This was a randomized, parallel-group, double-blind, double-dummy clinical trial. 132 patients a venlafaxine group (n=66) and a carbamazepine group (n=66) with painful peripheral diabetic neuropathy were recruited from 3 clinical centers. The venlafaxine group took venlafaxine 25 mg plus one dummy carbamazepine tablet twice a day and the carbamazepine group took carbamazepine 0.1 g plus one dummy venlafaxine tablet twice a day both for 2 weeks. The primary efficacy measurement consisted of a numeric pain intensity scale and the secondary measurement assessed quality of life. Results One hundred and nineteen patients completed the trial. Venlafaxine was superior to carbamazepine in improving mean pain intensity scores at 5,7,10 and 14 days by per-protocol analysis (P=0.02, P=0.03, P=0.003 and P=0.001 respectively). The effects of venlafaxine on the improvement in the total quality of life scores were better than those of carbamazepine at 10 and 14 days (P=0.02 and P=0.01 respectively). Sleep interference and mood were improved by both venlafaxine and carbamazepine, but the efficacy of venlafaxine was superior to that of carbamazepine. The common adverse events of venlafaxine included mild gastrointestinal discomfort, dizziness and somnolence. The frequency of adverse events in the venlafaxine group was about 43.9% (4 patients withdrew because of adverse events) and in the carbamazepine group about 25.76% (2 patients withdrew because of adverse events) (P =0.06). Conclusions Venlafaxine and carbamazepine are effective in the treatment of painful diabetic neuropathy, venlafaxine is superior to carbamazepine in improving pain and quality of life. Both drugs may be safe and well tolerated.

    Release date:2016-09-07 02:18 Export PDF Favorites Scan
  • The application of clinical multi-disciplinary team in the diagnosis and treatment of pituitary adenoma and related diseases

    Multi-disciplinary team (MDT) is increasingly applied in oncology and refractory diseases. In recent years, MDT has also been applied in diagnosis and treatment of pituitary adenoma and related diseases. This review summarizes the advantages and characteristics of the MDT diagnosis and treatment mode, and analyzes the application and effect of the MDT diagnosis and treatment mode in the Center of Pituitary Adenoma and Related Diseases, West China Hospital, Sichuan University. So far, it has shown that MDT has advantages such as it is professional, full of collaborative interaction, and efficient and optimized. It is a platform of multi-disciplinary cooperation and resources in the diagnosis and treatment of difficult diseases. Case discussion in MDT mode is conducive to timely selection of the best treatment options for patients with pituitary adenoma and related diseases, providing a good learning platform for doctors with different professional backgrounds, and promoting the improvement of professional diagnosis and treatment level of doctors in related departments. The development of MDT will help us to use limited medical resources efficiently, promote the medical team to be more specialized, optimize the diagnosis and treatment process, and improve the effectiveness of the treatment, for benefiting more patients with pituitary adenomas and related diseases.

    Release date:2018-12-24 02:03 Export PDF Favorites Scan
1 pages Previous 1 Next

Format

Content